Innobioscience SpA: Clinical Trials

1 trial sponsored by Innobioscience SpA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Innobioscience SpA: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS
Andrographolides, placebo - Primary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive
Phase 1 / Phase 2UnknownInnobioscience SpA682014-09-012014-10-27

Conditions studied

Multiple Sclerosis, Chronic Progressive (1)

Interventions

andrographolide (1)  ·  neoandrographolide (1)

Countries

Chile (1)

Top investigators

Juan L Hancke, DVM, PhD (1)

Results publications

PMID 32380977